B56. PULMONARY HYPERTENSION CLINICAL TRIALS ENDEAVOR SAFETY, COMBINATION WHAT ELSE?

130

微信好友朋友圈 QQ好友复制链接

查看最新文献

发文信息

B56. PULMONARY HYPERTENSION CLINICAL TRIALS ENDEAVOR SAFETY, COMBINATION WHAT ELSE? - 最新文献

查看全部

Transitioning Stable Pulmonary Arterial Hypertension Patients from Parenteral Prostacyclin Therapy to Oral Selexipag

Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3824 Colin Andrew Hinkamp, S. Bartolome, F. Torres, O. Igenoza, M. Kingman, S. Harden, K. Chin, T. Shah

A Double-Blind, Randomised, Placebo-Controlled, Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Zamicastat, in Healthy Male Volunteers

Pub Date : 2020-05-01 DOI: 10.1164/AJRCCM-CONFERENCE.2020.201.1_MEETINGABSTRACTS.A3816 Luís Magalhães, F. Rocha, A. Falcão, H. Gama, P. Soares-da-Silva

Initial combination therapy with macitentan and tadalafil in pulmonary arterial hypertension: a retrospective cohort study

Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3827 D. Marinescu, D. Christiansen, J. Thenganatt, J. Granton

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。